2020
DOI: 10.1074/mcp.ra119.001886
|View full text |Cite
|
Sign up to set email alerts
|

The Challenge of Classifying Metastatic Cell Properties by Molecular Profiling Exemplified with Cutaneous Melanoma Cells and Their Cerebral Metastasis from Patient Derived Mouse Xenografts

Abstract: The prediction of metastatic properties from molecular analyses still poses a major challenge. Here we aimed at the classification of metastasis-related cell properties by proteome profiling making use of cutaneous and brain-metastasizing variants from single melanomas sharing the same genetic ancestry. Previous experiments demonstrated that cultured cells derived from these xenografted variants maintain a stable phenotype associated with a differential metastatic behavior: The brain metastasizing variants pro… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
17
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8

Relationship

5
3

Authors

Journals

citations
Cited by 13 publications
(18 citation statements)
references
References 42 publications
1
17
0
Order By: Relevance
“…These results may constitute a relevant example of inter-tumor heterogeneity [ 44 ] reported recently by us to occur in melanoma cells derived from 4 individual melanoma patients [ 11 ]. Cutaneous and brain metastatic variant pairs from these melanomas, sharing the same genetic ancestry, were subjected to proteome profiling aiming to identify shared molecular pathways leading to brain metastasis.…”
Section: Discussionmentioning
confidence: 72%
See 1 more Smart Citation
“…These results may constitute a relevant example of inter-tumor heterogeneity [ 44 ] reported recently by us to occur in melanoma cells derived from 4 individual melanoma patients [ 11 ]. Cutaneous and brain metastatic variant pairs from these melanomas, sharing the same genetic ancestry, were subjected to proteome profiling aiming to identify shared molecular pathways leading to brain metastasis.…”
Section: Discussionmentioning
confidence: 72%
“…Each pair of variants originated thus from an identical genetic lineage [ 10 ]. Comparing transcriptomic [ 10 ], proteomic [ 11 ] and epigenomic [ 12 ] profiles of these variants, we identified and characterized a number of tumor-intrinsic and microenvironmental signaling factors as well as downstream factors. These three types of factors were involved in driving or inhibiting MBM formation, survival and preservation [ 7 , 8 , 9 , 10 , 13 , 14 , 15 , 16 , 17 , 18 ].…”
Section: Introductionmentioning
confidence: 99%
“…After a subsequent washing step, the stained cells were kept in Live Cell Imaging Solution and imaged within 1 h. Cells were imaged using a Zeiss LSM710 laser scanning confocal microscope (ELYRA PS.1 system) equipped with a 63X/1.2 water immersion objective (Zeiss Microscopy GmbH, Germany) or with the Lionheart FX Automated Microscope (BioTek Instruments, Winooski, VT, United States). For image analysis, the software ZEN 2012 Black Edition (Zeiss Microscopy GmbH, Germany), Gen5 (BioTek Instruments, Winooski, VT, United States), and the free software ImageJ were used as previously described ( Del Favero et al, 2018b ; Neuditschko et al, 2020 ). For the microfluidic slides, at least eight images were taken with the phase contrast, GFP (469/525 nm), and DAPI (377/447 nm) channels resulting in minimum 24 different optical fields for quantification.…”
Section: Methodsmentioning
confidence: 99%
“…To detect the morphological changes of the cells before and after the biomechanical stimulation, bright field images were acquired using an Olympus CKX53 Inverted Microscope. For every experiment, at least three images were acquired before (static controls) and after the biomechanical stimulation protocol (shear stress), resulting in a minimum of nine different optical fields for subsequent single-cell morphometric quantification ( Neuditschko et al, 2020 ).…”
Section: Methodsmentioning
confidence: 99%
“…For the identification and label free quantification of proteins, the MaxQuant software package (version 1.6.1.0) 97 was used 98 . The human UniProt database (version 03/2018, restricted to reviewed entries only) with 20316 entries was used for the search, and the false discovery rate (FDR) was set to 0.01 on both peptide and protein level.…”
Section: Methodsmentioning
confidence: 99%